BDBM644287 8-(4-{[2-hydroxy-4-(trifluoromethoxy)phenyl]methyl}piperazin-1-yl)-5-methyl-6-oxo-5,6-dihydro-1,5-naphthyridine-2,7-dicarbonitrile::US11866430, Example 265

SMILES Cn1c2ccc(nc2c(N2CCN(Cc3ccc(OC(F)(F)F)cc3O)CC2)c(C#N)c1=O)C#N

InChI Key InChIKey=UGAWCZSIIYWPFB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 644287   

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM644287(US11866430, Example 265 | 8-(4-{[2-hydroxy-4-(trif...)
Affinity DataIC50: 34nMAssay Description:The compound inhibition studies were carried out as follows: 50 nL droplets of each test compound (top concentration 10 mM with 11 point, 3-fold dilu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2024
Entry Details
US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM644287(US11866430, Example 265 | 8-(4-{[2-hydroxy-4-(trif...)
Affinity DataIC50: 3.60E+4nMAssay Description:The compound inhibition studies were carried out as follows: 50 nL droplets of each test compound (top concentration 10 mM with 11 point, 3-fold dilu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2024
Entry Details
US Patent